Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications: Frontiers of Nanoscience, cartea 16
Editat de Wolfgang Parak, Neus Feliuen Limba Engleză Paperback – 28 apr 2020
- Explores the use of nanotechnology in enhancing colloidal characterization techniques
- Explains how colloids are being used in a range of nanomedical applications
- Demonstrates how nanotechnology is being used to create more efficient colloidal synthesis techniques
Din seria Frontiers of Nanoscience
- 9% Preț: 792.39 lei
- 23% Preț: 800.24 lei
- 23% Preț: 876.81 lei
- 24% Preț: 871.47 lei
- 9% Preț: 900.69 lei
- 29% Preț: 987.03 lei
- 39% Preț: 872.24 lei
- 23% Preț: 994.10 lei
- 24% Preț: 987.98 lei
- 24% Preț: 987.90 lei
- 24% Preț: 850.26 lei
- 9% Preț: 787.73 lei
- 9% Preț: 700.26 lei
- 9% Preț: 787.63 lei
- 9% Preț: 790.23 lei
- 9% Preț: 984.26 lei
Preț: 988.33 lei
Preț vechi: 1386.11 lei
-29% Nou
Puncte Express: 1482
Preț estimativ în valută:
189.13€ • 196.34$ • 157.71£
189.13€ • 196.34$ • 157.71£
Carte tipărită la comandă
Livrare economică 17-31 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780081028285
ISBN-10: 0081028288
Pagini: 398
Dimensiuni: 191 x 235 mm
Greutate: 0.68 kg
Editura: ELSEVIER SCIENCE
Seria Frontiers of Nanoscience
ISBN-10: 0081028288
Pagini: 398
Dimensiuni: 191 x 235 mm
Greutate: 0.68 kg
Editura: ELSEVIER SCIENCE
Seria Frontiers of Nanoscience
Public țintă
Researchers in materials science, colloid chemistry and biomedicineCuprins
1. Colloids for Nanobiotechnology - An Introductio2. Surface-enhanced Raman scattering (SERS) sensing of nucleic acids3. Energy transfer with nanoparticles for in vitro diagnostic4. Nanoparticles for imaging application5. Colloidal nanoparticles as pharmaceutical agent6. Fluorescent nanoparticles for sensin7. Two-dimensional nanoparticles for the delivery of anticancer drugs and cancer therapy8. Engineered polymeric nanovehicles for drug deliver9. Polymer-based nanoparticles for biomedical applications10. Targeted delivery of nanoparticles11. Nanoparticles for immunotherap12. Targeted hyperthermia with plasmonic nanoparticles13. Current challenges and coming opportunities in nanoparticle risk assessment